Therapeutic potential of biodegradable microparticles containing Punica granatum L. (pomegranate) in murine model of asthma

Inflammation Research

Volumn 62, Issue 11, 2013, Pages 971-980

  De Oliveira, Jéssica F F ^a   Garreto, Diego V ^b   Da Silva, Mayara C P ^c   Fortes, Thiare S ^c   De Oliveira, Rejane B ^d   Nascimento, Flávia R F ^c   Da Costa, Fernando B ^d   Grisotto, Marcos A G ^a   Nicolete, Roberto ^a,e  

^a CEUMA UNIVERSITY   (Brazil)

^b Instituto Florence de Ensino Superior   (Brazil)

^c FEDERAL UNIVERSITY OF MARANHÃO   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Asthma; Inflammation; Microparticles; Poly(lactic co glycolic acid); Punica granatum L.

Indexed keywords

DEXAMETHASONE; INTERLEUKIN 1BETA; INTERLEUKIN 5; PLACEBO; POLYGLACTIN; POMEGRANATE EXTRACT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; BIODEGRADABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG FORMULATION; DRUG ISOLATION; DRUG TARGETING; ENCAPSULATION; EOSINOPHIL; EVAPORATION; EXPERIMENTAL MOUSE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LUNG FLUID; MOUSE; NONHUMAN; PARTICLE SIZE; PLANT LEAF; POMEGRANATE; QUALITATIVE RESEARCH; SOLVENT EXTRACTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; DISEASE MODELS, ANIMAL; DRUG CARRIERS; FEMALE; LACTIC ACID; LEUKOCYTES; LUNG; MICE; MICE, INBRED BALB C; PHYTOTHERAPY; PLANT EXTRACTS; PLANT LEAVES; POLYGLYCOLIC ACID; PUNICACEAE;

EID: 84888200936     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-013-0659-3     Document Type: Article

References (33)

1. Barnes PJ. Pathophysiology of asthma. Eur Respir Mon. 2003;8:84-113.
2. Tattersfield AE, Knox AJ, Britton JR, Hall IP. Asthma. Lancet. 2002;360:1313-22.
3. Barnes PJ. New drugs for asthma. Nat Rev Drug Discov. 2004;3:831-44.
4. Yang EJ, Lee JS, Yun CY, Kim JH, Kim JS, Kim DH, Kim IS. Inhibitory effects of Duchesnea chrysantha extract on ovalbumin-induced lung inflammation in a mouse model of asthma. J Ethnopharmacol. 2008;118:102-7.
5. Yuk JE, Woo JS, Yun CY, Lee JS, Kim JH, Song GY, Yang EJ, Hur IK, Kim IS. Effects of lactose-β-sitosterol and β-sitosterol on ovalbumin-induced lung inflammation in actively sensitized mice. Int Immunopharmacol. 2007;7:1517-27.
6. Clardy J, Walsh C. Lessons from natural molecules. Nature. 2004;432:829-37.
7. Verpoorte R. Exploration of nature's chemodiversity: the role of secondary metabolites as leads in drug development. Drug Discov Today. 1999;3:232-8.
8. Koehn FE, Carter GT. The evolving role of natural products in drug discovery. Nat Rev Drug Discov. 2005;4:206-20.
9. Rogerio AP, Fontanari C, Borducchi E, Keller AC, Russo M, Soares EG, Albuquerque DA, Faccioli LH. Anti-inflammatory effects of Lafoensia pacari and ellagic acid in a murine model of asthma. Eur J Pharmacol. 2008;580:262-70.
10. Rogerio AP. SÁ-NUNES A, Faccioli LH. The activity of medicinal plants and secondary metabolites on eosinophilic inflammation. Pharmacol Res. 2010;62:298-307.
11. Jurenka JS. Therapeutic applications of pomegranate (Punica granatum L.): a review. Altern Med Rev. 2008;13:128-44.
12. Fischer UA, Carle R, Kammerer DR. Identification and quantification of phenolic compounds from pomegranate (Punica granatum L.) peel, mesocarp, aril and differently produced juices by HPLC-DAD-ESI/MSn. Food Chem. 2011;127:807-21.
13. Lansky EP, Newman RA. Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer. J Ethnopharmacol. 2007;109:177-206.
14. Lansky E, Shubert S, Newman I. Pharmacological and therapeutic properties of pomegranate. CIHEAM-Options Mediterraneennes. 2004; 231-235.
15. Lee SI, Kim BS, Kim KS, Lee S, Shin KS, Lim JS. Immune-suppressive activity of punicalagin via inhibition of NFAT activation. Biochem Biophys Res Commun. 2008;371:799-803.
16. Romier B, Van De Walle J, During A, Larondelle Y, Schneider YJ. Modulation of signalling nuclear factor-kappaB activation pathway by polyphenols in human intestinal Caco-2 cells. Br J Nutr. 2008;100:542-51.
17. Nicolete R, Lima KM, Rodrigues Júnior JM, Baruffi MD, Medeiros AI, Bentley MVLB, Silva CL, Faccioli LH. In vitro and in vivo activities of leukotrienes B4-loaded biodegradable microspheres. Prostaglandins Other Lipid Mediators. 2007;83:121-9.
18. Nicolete R, Rius C, Piqueras L, Jose PJ, Sorgi CA, Soares EG, Sanz MJ, Faccioli LH. Leukotriene B4-loaded microspheres: a new therapeutic strategy to modulate cell activation. BMC Immunol. 2008;9:1-11.
19. Oh YJ, Lee J, Seo JY, Rhim T, Kim S, Yoon HJ, Lee KY. Preparation of budesonide-loaded porous PLGA microparticles and their therapeutic efficacy in a murine asthma model. J Controlled Release. 2011;150:56-62.
20. Sung JC, Pulliam BL, Edwards DA. Nanoparticles for drug delivery to the lungs. Trends Biotechnol. 2007;25:563-70.
21. Pilcer G, Amighi K. Formulation strategy and use of excipients in pulmonary drug delivery. Int J Pharm. 2010;392:1-19.
22. Bekir J, Mars M, Souchard JP, Bouajila J. Assessment of antioxidant, anti-inflammatory, anti-cholinesterase and cytotoxic activities of pomegranate (Punica granatum) leaves. Food Chem Toxicol. 2013;55:470-5.
23. Gil MI, Tomás-Barberán FA, Hess-Pierce B, Holcroft DM, Kader AA. Antioxidant Activity of Pomegranate Juice and Its Relationship with Phenolic Composition and Processing. J Agric Food Chem. 2000;48:4581-9.
24. Ismail T, Sestili P, Akhtar S. Pomegranate peel and fruit extracts: a review of potential anti-inflammatory and anti-infective effects. J Ethnopharmacol. 2012;143:397-405.
25. Wager S, Lundblad LKA, Ekman M, Irvin CG, Bates JHT. The allergic mouse model of asthma: normal smooth muscle in an abnormal lung? J Appl Physiol. 2004;96:2019-27.
26. Nicolete R, Secatto A, Pereira PAT, Soares EG, Faccioli LH. Leukotriene B4-loaded microspheres as a new approach to enhance antimicrobial responses in Histoplasma capsulatum-infected mice. Int J Antimicr Agets. 2009;4:365-9.
27. Cook-Mills JM, Deem TL. Active participation of endothelial cells in inflammation. J Leukoc Biol. 2005;77:487-95.
28. Balwani S, Nandi D, Jaisankar P, Ghosh B. 2-Methyl-pyran-4-one-3-O- β-D-glucopyranoside isolated from leaves of Punica granatum inhibits the TNFα-induced cell adhesion molecules expression by blocking nuclear transcription factor-kB (NF-kB). Biochimie. 2011;93:921-30.
29. Nicolete R, Santos DF, Faccioli LH. The uptake of PLGA micro or nanoparticles by macrophages provokes distinct in vitro inflammatory response. Int Immunopharmacol. 2011;11:1557-63.
30. Whelan R, Kim C, Chen M, Leiter J, Grunstein MM, Hakonarson H. Role and regulation of interleukin-1 molecules in pro-asthmatic sensitised airway smooth muscle. Eur Respir J. 2004;24:559-67.
31. Faccioli LH, Mokwa VF, Silva CL, Rocha GM, Araujo JI, Nahori MA, Vargaftig BB. IL-5 drives eosinophils from bone marrow to blood and tissues in a guinea-pig model of visceral larva migrans syndrome. Mediators Inflamm. 1996;5:24-31.
32. Rogerio AP, Sá-Nunes A, Albuquerque DA, Anibal FF, Medeiros AI, Machado ER, Souza AO, Prado JC Jr, Faccioli LH. Lafoensia pacari extract inhibits IL-5 production in toxocariasis. Parasite Immunol. 2003;25:393-400.
33. Lampinen M, Carlson M, Hakansson LD, Venge P. Cytokine-regulated accumulation of eosinophils in inflammatory disease. Allergy. 2004;59:793-805.